PolyPeptide Group Balance Sheet Health
Financial Health criteria checks 5/6
PolyPeptide Group has a total shareholder equity of €359.9M and total debt of €91.7M, which brings its debt-to-equity ratio to 25.5%. Its total assets and total liabilities are €665.0M and €305.1M respectively.
Key information
25.5%
Debt to equity ratio
€91.72m
Debt
| Interest coverage ratio | n/a |
| Cash | €48.48m |
| Equity | €359.92m |
| Total liabilities | €305.05m |
| Total assets | €664.97m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: PPGNZ's short term assets (€292.6M) exceed its short term liabilities (€183.6M).
Long Term Liabilities: PPGNZ's short term assets (€292.6M) exceed its long term liabilities (€121.4M).
Debt to Equity History and Analysis
Debt Level: PPGNZ's net debt to equity ratio (12%) is considered satisfactory.
Reducing Debt: PPGNZ's debt to equity ratio has reduced from 30.5% to 25.5% over the past 5 years.
Debt Coverage: PPGNZ's debt is well covered by operating cash flow (93%).
Interest Coverage: Insufficient data to determine if PPGNZ's interest payments on its debt are well covered by EBIT.